BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2536 related articles for article (PubMed ID: 27472390)

  • 1. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy.
    Liu L; Wang W; Zhang Y; Long J; Zhang Z; Li Q; Chen B; Li S; Hua Y; Shen S; Peng B
    Cancer Res Treat; 2018 Apr; 50(2):538-550. PubMed ID: 28602056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
    Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
    Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.
    Yang HJ; Guo Z; Yang YT; Jiang JH; Qi YP; Li JJ; Li LQ; Xiang BD
    World J Gastroenterol; 2016 Jun; 22(21):5088-95. PubMed ID: 27275101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
    Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
    Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
    Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
    Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
    Zheng J; Seier K; Gonen M; Balachandran VP; Kingham TP; D'Angelica MI; Allen PJ; Jarnagin WR; DeMatteo RP
    Ann Surg Oncol; 2017 Nov; 24(12):3706-3714. PubMed ID: 28840521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
    Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Pre-surgical Combined Platelet Count and Neutrophil-Lymphocyte Ratio for Patients With Hepatocellular Carcinoma.
    Uchinaka EI; Amisaki M; Yagyu T; Morimoto M; Watanabe J; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    In Vivo; 2019; 33(6):2241-2248. PubMed ID: 31662563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.
    Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
    World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.